A study of splenomegaly and of changes in numbers of nucleated cell types circulating in the blood of Rauscher leukemia virus (RLV)-infected mice has been performed and related to the recently reported pattern of development of radioresistance in these animals. Splenomegaly was first apparent as a 2-fold increase in spleen weight 10 days after RLV infection, with spleen weights increasing rapidly thereafter. The total number of circulating lymphocytes or granulocytes did not change until 18 days after infection, after which time there was a marked rise in the number of cells in both populations reaching maximum numbers that were 5-fold normal. Increased numbers of circulating nucleated erythroid cells and "smudge" cells were seen by the 14th day of infection. "Smudge" cell numbers increased by 100-fold over the next 2 weeks and nucleated erythroid cell numbers increased by 1000-fold during the same period. Thus, the Rauscher disease-induced changes in the mature blood cell population do not appear to be responsible for the early (10 day) appearance of radioresistance after RLV infection but may contribute to the maintenance of radioresistance at later times. In contrast, development of splenomegaly correlates well with the initial appearance of radioresistance, and increasing spleen size thereafter appears to be related to increasing radioresistance as the infection progresses.
Skip Nav Destination
Close
Article navigation
1 March 1973
Research Article|
March 01 1973
Radioprotective Effect of Rauscher Leukemia Virus in the SJL/J Mouse: III. Relationship of Hematologic Factors and Splenomegaly to the Development of Radioresistance
Radiat Res (1973) 53 (3): 428–434.
Citation
Arnold M. Markoe, James P. Okunewick; Radioprotective Effect of Rauscher Leukemia Virus in the SJL/J Mouse: III. Relationship of Hematologic Factors and Splenomegaly to the Development of Radioresistance. Radiat Res 1 March 1973; 53 (3): 428–434. doi: https://doi.org/10.2307/3573775
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group
Hualin Zhang, Xiaodong Wu, Xin Zhang, Sha X. Chang, Ali Megooni, Eric D. Donnelly, Mansoor M. Ahmed, Robert J. Griffin, James S. Welsh, Charles B. Simone, II, Nina A. Mayr